, Volume 58, Supplement 2, pp 417–419 | Cite as

Pharmacodynamic Activity of Levofloxacin in an In Vitro Model Against Gram-Positive and Gram-Negative Bacteria

  • B. Wiedemann
  • E. Pfeil
Poster Presentations Extended Abstract


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Keil S, Wiedemann B. Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models. Antimicrob Agents Chemother 1995; 39: 1054–8PubMedCrossRefGoogle Scholar
  2. 2.
    National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria which grow aerobically. Approved standard M7-T. Villanova, PA: NCCLS, 1996Google Scholar
  3. 3.
    Grasso SG, Meinardi G, de Caneri I, et al. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob Agents Chemother 1978; 13: 570–6PubMedCrossRefGoogle Scholar
  4. 4.
    Borner K, Höffken G, Lode H, et al. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol Infect Dis 1986; 5: 179–86CrossRefGoogle Scholar
  5. 5.
    Rüstige C, Wiedemann B. Antibacterial activity of lomefloxacin in an in vitro model. Antimicrob Agents Chemother 1990; 34: 1107–11PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • B. Wiedemann
    • 1
  • E. Pfeil
    • 1
  1. 1.Department of Pharmaceutical MicrobiologyUniversity of BonnBonnGermany

Personalised recommendations